Cheng‐Keng Chuang
Papers
6
Total Citations
25
H-Index
3
About
Dr. Cheng-Keng Chuang is a urologic surgeon and researcher whose work focuses on improving outcomes for patients with urologic cancers, particularly prostate and renal cell carcinoma. His major contributions lie at the intersection of robotic-assisted surgery, artificial intelligence, and predictive modeling. He has pioneered the use of deep learning to analyze postoperative cystography features, enabling rapid prediction of urinary incontinence recovery after prostatectomy (2023, 8 citations). Dr. Chuang has also advanced nephron-sparing techniques, demonstrating the efficacy of robot-assisted partial nephrectomy for renal tumors (2019, 6 citations). His research on clinical predictors for biochemical failure after robotic radical prostatectomy (2021, 4 citations) helps identify high-risk patients with positive surgical margins. Notably, his 2024 study on periprostatic adipose tissue revealed a novel natural barrier that secretes apoptotic factors to inhibit early prostate cancer progression, offering new insights into tumor immunology. With a growing portfolio of work integrating clinical and imaging parameters into simplified nomograms, Dr. Chuang is shaping precision medicine in urologic oncology, making complex risk assessments more accessible for clinical decision-making.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6